Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kezar Life Sciences Inc
2KZCurrent price
0.7 EUR
-0.005 EUR (-0.71%)
Last closed
7.43 USD
Company
www.kezarlifesciences.com
ISIN
US49372L1008
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
52 605 748 USD
Yield for 12 month
-11.52 %
1Y
3Y
5Y
10Y
15Y
2KZ
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Address: 4000 Shoreline Court, South San Francisco, CA, United States, 94080
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
25 USDP/E ratio
–Dividend Yield
–Current Year
+7 000 000 USD
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
+5 934 000 USD
Last Year
-1 022 999 USD
Current Quarter
-261 000 USD
Last Quarter
-260 000 USD
Key Figures 2KZ
1 year
3 years
5 years
10 years
EBITDA
-98 462 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.07 %
PEG Ratio
–
Return On Equity TTM
-51.48 %
Wall Street Target Price
25 USD
Revenue TTM
7 000 000 USD
Book Value
20.67 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-13.5 USD
Diluted Eps TTM
-13.5 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 2KZ
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2KZ
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
30.10.2024
Dividend Date
–
Stock Valuation 2KZ
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
7.5151
Enterprise Value EBITDA
0.0597
Price Book MRQ
0.3491
Financials 2KZ
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2KZ
For 52 weeks
5.2 USD
11.35 USD
50 Day MA
6.93 USD
Shares Short Prior Month
982 903
200 Day MA
7.53 USD
Short Ratio
0.64
Shares Short
1 194 636
Short Percent
1.68 %
BeatStart